Armstrong Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-437
Closed -$34.2K – 1074
2026
Q2
$34.2K Hold
437
– – ﹤0.01% 502
2026
Q1
$37.9K Hold
437
– – ﹤0.01% 457
2025
Q4
$42K Hold
437
– – ﹤0.01% 423
2025
Q3
$41.6K Hold
437
– – ﹤0.01% 426
2025
Q2
$38.1K Sell
437
-886
-67% -$75.1K ﹤0.01% 427
2025
Q1
$106K Hold
1,323
– – 0.01% 268
2024
Q4
$106K Hold
1,323
– – 0.01% 268
2024
Q3
$119K Sell
1,323
-16
-1% -$1.35K 0.01% 249
2024
Q2
$105K Sell
1,339
-148
-10% -$12.1K 0.01% 250
2024
Q1
$122K Hold
1,487
– – 0.01% 224
2023
Q4
$122K Sell
1,487
-323
-18% -$24.6K 0.01% 224
2023
Q3
$142K Sell
1,810
-123
-6% -$10.3K 0.02% 196
2023
Q2
$170K Hold
1,933
– – 0.02% 191
2023
Q1
$156K Hold
1,933
– – 0.02% 188
2022
Q4
$150K Buy
+1,933
New +$157K 0.02% 192

Other funds holding MDT

Armstrong Advisory Group's MDT Position: Q3 2026 in Review

Armstrong Advisory Group sold out of Medtronic (MDT) in Q3 2026, closing a stake of 437 shares — an estimated $34.2K sold.

Armstrong Advisory Group first reported a position in MDT in Q4 2022 and held it in 15 quarters. The position peaked at $170K in Q2 2023. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Armstrong Advisory Group reported no remaining Medtronic position as of Q3 2026 after selling out during the quarter.
  • Armstrong Advisory Group sold 437 Medtronic shares in Q3 2026, an estimated $34.2K.
  • Armstrong Advisory Group first reported a position in Medtronic in Q4 2022 and held it in 15 quarters.
  • Armstrong Advisory Group's Medtronic position peaked at $170K in Q2 2023.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.